Back to medications
Medication monograph
durvalumab
PD-L1 InhibitorsAntineoplasticsImmunotherapy AgentsProgrammed Death Ligand-1 BlockerChemotherapeutic Agents
Clinical reference
Product monograph
IMFINZI- durvalumab injection, solution
Brands & formulations
Family members
Classification
- Chemical class
- PD-L1 Inhibitors
- Clinical class
- Antineoplastics, Immunotherapy Agents
- Banks class
- Programmed Death Ligand-1 Blocker
- AHFS family
- Chemotherapeutic Agents